$30,000 of MIMEDX lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"regulatory issues related to the delivery of wound management and skin substitutes for Medicare patients"
You can find more data on corporate lobbying on Quiver Quantitative.
MDXG Hedge Fund Activity
We have seen 132 institutional investors add shares of MDXG stock to their portfolio, and 110 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STATE STREET CORP added 1,243,005 shares (+32.6%) to their portfolio in Q1 2026, for an estimated $4,909,869
- HILLSDALE INVESTMENT MANAGEMENT INC. removed 1,052,400 shares (-99.9%) from their portfolio in Q1 2026, for an estimated $4,156,980
- TRIGRAN INVESTMENTS, INC. added 1,011,725 shares (+16.4%) to their portfolio in Q1 2026, for an estimated $3,996,313
- NANTAHALA CAPITAL MANAGEMENT, LLC added 980,910 shares (+40.6%) to their portfolio in Q1 2026, for an estimated $3,874,594
- DEUTSCHE BANK AG\ added 907,036 shares (+708.7%) to their portfolio in Q1 2026, for an estimated $3,582,792
- DISCIPLINED GROWTH INVESTORS INC /MN removed 843,828 shares (-56.9%) from their portfolio in Q1 2026, for an estimated $3,333,120
- AMERIPRISE FINANCIAL INC removed 595,549 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,352,418
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MDXG Analyst Ratings
Wall Street analysts have issued reports on $MDXG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 04/30/2026
- Mizuho issued a "Outperform" rating on 12/17/2025
To track analyst ratings and price targets for MDXG, check out Quiver Quantitative's $MDXG forecast page.
MDXG Price Targets
Multiple analysts have issued price targets for $MDXG recently. We have seen 5 analysts offer price targets for $MDXG in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- David Turkaly from Citizens set a target price of $6.0 on 04/30/2026
- Chase Knickerbocker from Craig-Hallum set a target price of $7.0 on 04/17/2026
- Sarah James from Cantor Fitzgerald set a target price of $8.0 on 02/17/2026
- Brooks O'Neil from Lake Street set a target price of $10.0 on 01/20/2026
- Anthony Petrone from Mizuho set a target price of $10.0 on 12/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
